Edition:
India

Dova Pharmaceuticals Inc (DOVA.OQ)

DOVA.OQ on NASDAQ Stock Exchange Global Market

9.26USD
19 Mar 2019
Change (% chg)

$0.28 (+3.12%)
Prev Close
$8.98
Open
$9.02
Day's High
$9.29
Day's Low
$8.89
Volume
37,926
Avg. Vol
92,736
52-wk High
$35.33
52-wk Low
$5.62

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.70 December 20 Mar 2019

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 2 2 2 2
(2) OUTPERFORM 1 1 3 2
(3) HOLD 2 2 2 2
(4) UNDERPERFORM 1 1 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.33 2.33 2.00 2.00

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Mar-19 3 4.29 4.50 4.00 --
Quarter Ending Jun-19 3 5.61 7.00 4.00 --
Year Ending Dec-19 5 32.68 41.30 29.00 173.09
Year Ending Dec-20 5 95.38 120.31 55.00 278.60
Earnings (per share)
Quarter Ending Mar-19 4 -0.70 -0.66 -0.74 0.53
Quarter Ending Jun-19 4 -0.71 -0.61 -0.80 0.99
Year Ending Dec-19 5 -2.34 -1.85 -2.89 0.61
Year Ending Dec-20 5 -0.65 0.49 -1.92 3.81

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Dec-18 2.89 2.84 0.05 1.69
Quarter Ending Sep-18 2.46 2.93 0.47 19.06
Quarter Ending Jun-18 0.10 4.58 4.48 4,484.00
Quarter Ending Mar-18 0.00 0.00 0.00 0.00
Quarter Ending Dec-17 0.00 0.00 0.00 0.00

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Mar-19 4.29 4.29 5.23 4.53 --
Quarter Ending Jun-19 5.61 5.61 7.47 7.12 --
Year Ending Dec-19 32.68 32.68 36.39 40.49 173.09
Year Ending Dec-20 95.38 95.38 116.56 134.24 278.60

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Mar-19 0 0 0 1
Quarter Ending Jun-19 0 0 0 1
Year Ending Dec-19 0 0 0 3
Year Ending Dec-20 0 0 0 3
Earnings